Europe Laboratory Information System (LIS) Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Standalone LIS and Integrated LIS), Delivery Mode (Cloud-Based Delivery Mode, Web-Based Delivery Mode, and On-Premises Delivery Mode),

Europe Laboratory Information System (LIS) Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Standalone LIS and Integrated LIS), Delivery Mode (Cloud-Based Delivery Mode, Web-Based Delivery Mode, and On-Premises Delivery Mode), Component (Software and Services), and End User (Hospital Labs, Independent Labs, and Physician Office Labs)

The laboratory information system (LIS) market in Europe is expected to grow from US$ 244.03 million in 2022 to US$ 431.39 million by 2028. It is estimated to grow at a CAGR of 10.0% from 2022 to 2028.

Technological Advancements in LIS

Informatics platforms save time and money as they help to avoid rework if error occurred, and other technical glitches persists. The LIS solutions ensure that samples are only sent or assigned to instruments that are regularly monitored as well as accurately calibrated and maintained as per schedule. Due to technological developments and far exceeding complexities in laboratory process, the scope of LIS has gone beyond data, process, and product management. Moreover, mobility is one of the driving forces of the new technological era, wherein the remote management of laboratories are likely to be indispensable. Cloud-based delivery mode LIS has also been considered to meet the problem of limited geographic coverage associated with the traditional LIS systems. These systems eliminate the need of heavy capital investments in infrastructure and enables fast and safe data transfer within the organizations.

The laboratory information system (LIS) market players are coming up with innovative solutions to sustain their presence in the highly competitive market. For instance, Autoscribe Informatics launched an updated version of its Regulated Manufacturing LIMS, in March 2021; it is a configured solution based on the Matrix Gemini LIS solution. The product is ideal for all manufacturing organizations, including the highly regulated industries such as medical devices and pharmaceuticals. This web-enabled version is intended to improve the experience of users both from a visual aesthetic perspective and also providing additional flexibility in user setup, dashboard, reports, and other components which are important to SoftBank users. The software features a single, integrated platform with one user interface. It furthermore includes configurable workflows, the ability to automate routine tasks, and data exchange tools. In July 2021, LabVantage Solutions, Inc. launched a new edition of its flagship LabVantage LIMS. The LabVantage LIS 8.7 portal features systems that manage the laboratory’s data security, along with offering self-service access to external customers.

It also allows laboratories to go live faster and at a lower total cost. Thus, the developments and innovations by the market players are boosting the growth of global laboratory information system (LIS) market.

Market Overview

The market for Europe laboratory information system (LIS) market is segmented into the Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global laboratory information management systems market and is expected to record vigorous growth rate during the forecast period. The growth of the market is attributed by increasing R&D expenditure along with rapid growth of the pharmaceutical companies and increased adoption of information technology solutions for clinical decision support, which will drive the market growth.

The market for laboratory information system is likely to grow due to the increasing development in the healthcare sector. Germany is the biggest market for medical technology in the European region. According to the Germany Trade & Invest in 2019, Germany was responsible for 33.4 billion sales (domestic and exports) billion sales of the medical technology industry. It also mentioned that German Medical Technology Industry in 2019 spent 9% of its annual turnover on R&D expenses. Thus, German market for laboratory information system is being driven by the increasing expenditure on healthcare research and the increasing automation in diagnostic laboratories. For instance, in September 2020, the German health ministry has announced €3 billion for hospitals to invest in modern emergency capacities, digitization, and IT security. The funding for projects will be provided under the future hospital fund (KHZF). This will cover 70% of projects, and 30% will be funded by the federal states/ hospital operators, which will raise a further €1.3 billion. Also, Germany is ranked as a leader in clinical trials conducted in Europe and ranked as among top 5 in the world. Clinical trial data quality is at par with the US, costs are up to 50 percent lower in Germany. According to a report published by the Germany Trade & Invest, at least 45 university hospitals and 118 clinical institutes are involved in clinical trials in Germany. The Charité in Berlin is Europe’s largest university hospital. German hospitals are renowned for their consistent and reliable collection of data in clinical test series. Apart from this, the increasing efforts to digitalize healthcare services is driving the market’s growth. This can be related to the high capital investments dedicated for the development, research, and manufacturing of new medical technologies, thus expected to drive the growth for Laboratory Information Management Systems market in the country.

Europe Laboratory Information System (LIS) Market Revenue and Forecast to 2028 (US$ Million)

Europe Laboratory Information System (LIS) Market Segmentation

The Europe laboratory information system (LIS) market is segmented into product, delivery mode, component, end user, and country.

Based on product, the market is bifurcated into standalone LIS and integrated LIS. The standalone LIS segment held the larger market share in 2022.

Based on delivery mode, the market is segmented into cloud-based delivery mode, web-based delivery mode, and on-premises delivery mode. Cloud-based delivery mode segment held the largest market share in 2022.

Based on component, the market is segmented into software and services. Software segment held the larger market share in 2022.

Based on end user, the market is segmented into hospital labs, independent labs, and physician office labs. The hospital labs segment held the largest market share in 2022.

Based on country, the market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the market share in 2022.

AAC Infotray AG; CompuGroup Medical; Illumina, Inc.; LabLynx, Inc.; LabVantage Solutions, Inc.; McKESSON CORPORATION; and Thermo Fisher Scientific Inc. are the leading companies operating in the laboratory information system (LIS) market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM GPU database market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM GPU database market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the GPU database market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution